KORU Medical Systems (KRMD) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

KRMD Stock Forecast


KORU Medical Systems stock forecast is as follows: an average price target of $3.25 (represents a -12.16% downside from KRMD’s last price of $3.70) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

KRMD Price Target


The average price target for KORU Medical Systems (KRMD) is $3.25 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $3.50 to $3.00. This represents a potential -12.16% downside from KRMD's last price of $3.70.

KRMD Analyst Ratings


Buy

According to 3 Wall Street analysts, KORU Medical Systems's rating consensus is 'Buy'. The analyst rating breakdown for KRMD stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

KORU Medical Systems Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 14, 2024Matthew O\'BrienPiper Sandler$3.50$3.1013.09%-5.41%
Jul 02, 2024Kyle RoseCanaccord Genuity$3.00$2.2533.33%-18.92%
Jan 06, 2023Piper Sandler$4.50$3.7021.62%21.62%
May 05, 2022Jason BednarPiper Sandler$3.00$2.807.14%-18.92%

The latest KORU Medical Systems stock forecast, released on Nov 14, 2024 by Matthew O\'Brien from Piper Sandler, set a price target of $3.50, which represents a 13.09% increase from the stock price at the time of the forecast ($3.10), and a -5.41% decrease from KRMD last price ($3.70).

KORU Medical Systems Price Target by Period


1M3M12M
# Anlaysts-12
Avg Price Target-$3.50$3.25
Last Closing Price$3.70$3.70$3.70
Upside/Downside-100.00%-5.41%-12.16%

In the current month, the average price target of KORU Medical Systems stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to KORU Medical Systems's last price of $3.70. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Nov 14, 2024Piper SandlerOverweightOverweightHold
Aug 08, 2024Piper SandlerNeutralNeutralHold
Aug 08, 2024Piper SandlerOverweightOverweightHold
Jul 02, 2024Canaccord GenuityBuyBuyHold
Sep 07, 2023B. RileyBuyInitialise
Nov 10, 2022Piper SandlerOverweightUpgrade
Nov 10, 2022Canaccord GenuityBuyUpgrade

KORU Medical Systems's last stock rating was published by Piper Sandler on Nov 14, 2024. The company gave KRMD a "Overweight" rating, the same as its previous rate.

KORU Medical Systems Financial Forecast


KORU Medical Systems Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$7.00M$6.94M$7.39M$7.34M$7.76M$6.55M$6.24M$6.49M$6.04M$5.53M$5.43M$4.06M$6.08M$7.71M$6.33M$6.22M$6.62M
Avg Forecast$11.82M$11.15M$10.72M$10.07M$10.38M$9.66M$9.34M$8.78M$8.13M$7.67M$7.57M$7.48M$6.94M$7.93M$6.90M$7.44M$7.38M$6.78M$6.29M$6.06M$6.06M$5.42M$5.20M$5.10M$4.69M$7.11M$6.53M$6.20M$5.36M$5.48M
High Forecast$12.14M$11.45M$11.01M$10.35M$10.66M$9.92M$9.60M$8.96M$8.25M$7.68M$7.57M$7.68M$7.13M$7.93M$7.09M$7.64M$7.58M$6.78M$6.29M$6.06M$6.06M$5.42M$5.20M$5.10M$4.69M$7.11M$6.53M$6.20M$5.36M$5.48M
Low Forecast$11.54M$10.89M$10.47M$9.84M$10.14M$9.43M$9.13M$8.59M$8.01M$7.67M$7.57M$7.31M$6.93M$7.93M$6.74M$7.27M$7.21M$6.78M$6.29M$6.06M$6.06M$5.42M$5.20M$5.10M$4.69M$7.11M$6.53M$6.20M$5.36M$5.48M
# Analysts111111133111311111111111111111
Surprise %-------------0.88%1.01%0.99%1.00%1.14%1.04%1.03%1.07%1.11%1.06%1.06%0.87%0.86%1.18%1.02%1.16%1.21%

KORU Medical Systems's average Quarter revenue forecast for Dec 23 based on 3 analysts is $6.94M, with a low forecast of $6.93M, and a high forecast of $7.13M. KRMD's average Quarter revenue forecast represents a -0.84% decrease compared to the company's last Quarter revenue of $7.00M (Sep 23).

KORU Medical Systems EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111133111311111111111111111
EBITDA-------------$-1.56M$-2.88M$-2.79M$-2.32M$-1.36M$-3.47M$-3.01M$-1.99M$-1.20M$-1.26M$-2.08M$-1.06M$451.77K$3.76M$878.86K$1.80M$2.64M
Avg Forecast$-1.70M$-1.61M$-1.54M$-1.45M$-1.50M$-1.39M$-1.35M$-1.26M$-1.17M$-1.11M$-1.09M$-4.84M$-1.00M$-1.14M$-994.27K$-3.83M$-108.66K$-639.21K$-592.43K$-3.03M$-571.51K$-511.19K$-490.43K$-2.10M$-441.71K$-669.99K$-615.74K$678.58K$-505.39K$-516.28K
High Forecast$-1.66M$-1.57M$-1.51M$-1.42M$-1.46M$-1.36M$-1.32M$-1.24M$-1.15M$-1.11M$-1.09M$-3.88M$-999.21K$-1.14M$-971.45K$-3.06M$-86.93K$-639.21K$-592.43K$-2.42M$-571.51K$-511.19K$-490.43K$-1.68M$-441.71K$-669.99K$-615.74K$814.30K$-505.39K$-516.28K
Low Forecast$-1.75M$-1.65M$-1.59M$-1.49M$-1.54M$-1.43M$-1.38M$-1.29M$-1.19M$-1.11M$-1.09M$-5.81M$-1.03M$-1.14M$-1.02M$-4.60M$-130.39K$-639.21K$-592.43K$-3.63M$-571.51K$-511.19K$-490.43K$-2.52M$-441.71K$-669.99K$-615.74K$542.86K$-505.39K$-516.28K
Surprise %-------------1.37%2.90%0.73%21.38%2.12%5.85%0.99%3.49%2.35%2.58%0.99%2.39%-0.67%-6.11%1.30%-3.55%-5.12%

1 analysts predict KRMD's average Quarter EBITDA for Dec 20 to be $-441.71K, with a high of $-441.71K and a low of $-441.71K. This is -197.77% lower than KORU Medical Systems's previous annual EBITDA (Sep 20) of $451.77K.

KORU Medical Systems Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111133111311111111111111111
Net Income-------------$-1.37M$-2.50M$-2.41M$-1.98M$-1.23M$-2.92M$-2.54M$-1.07M$-1.09M$-1.12M$-1.28M$-834.63K$249.18K$-1.08M$449.43K$-80.26K$651.81K
Avg Forecast$139.43K$-417.15K$-473.32K$-908.03K$-618.99K$-932.61K$-1.03M$-1.02M$-1.33M$-1.79M$-1.97M$-4.06M$-1.83M$-2.29M$-2.60M$-3.21M$-175.05K$-2.48M$-2.92M$-2.54M$-1.55M$-1.12M$-916.23K$-1.28M$-260.85K$899.28K$916.23K$449.43K$458.11K$229.06K
High Forecast$144.39K$-404.70K$-459.19K$-880.94K$-600.52K$-904.78K$-1.00M$-834.49K$-1.16M$-1.73M$-1.91M$-3.25M$-1.38M$-2.22M$-2.52M$-2.57M$-140.04K$-2.48M$-2.92M$-2.03M$-1.55M$-1.12M$-916.23K$-1.02M$-260.85K$899.28K$916.23K$539.31K$458.11K$229.06K
Low Forecast$135.27K$-431.99K$-490.16K$-940.34K$-641.01K$-965.79K$-1.07M$-1.21M$-1.49M$-1.85M$-2.04M$-4.87M$-2.29M$-2.37M$-2.69M$-3.85M$-210.06K$-2.48M$-2.92M$-3.05M$-1.55M$-1.12M$-916.23K$-1.53M$-260.85K$899.28K$916.23K$359.54K$458.11K$229.06K
Surprise %-------------0.60%0.96%0.75%11.29%0.49%1.00%1.00%0.69%0.98%1.23%1.00%3.20%0.28%-1.17%1.00%-0.18%2.85%

KORU Medical Systems's average Quarter net income forecast for Dec 20 is $-260.85K, with a range of $-260.85K to $-260.85K. KRMD's average Quarter net income forecast represents a -204.69% decrease compared to the company's last Quarter net income of $249.18K (Sep 20).

KORU Medical Systems SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111133111311111111111111111
SG&A-------------$4.62M$5.30M$5.43M$4.76M$4.83M$5.53M$5.49M$4.88M$3.90M$4.09M$4.99M$2.99M$3.08M$3.20M$2.76M$2.80M$2.44M
Avg Forecast$7.40M$6.98M$6.72M$6.31M$6.50M$6.05M$5.85M$5.50M$5.09M$4.81M$4.74M$4.69M$4.35M$4.97M$4.32M$6.95M$6.29M$4.25M$3.94M$5.49M$3.80M$3.40M$3.26M$4.99M$2.94M$4.45M$4.09M$2.85M$3.36M$3.43M
High Forecast$7.61M$7.18M$6.90M$6.48M$6.68M$6.22M$6.01M$5.61M$5.17M$4.81M$4.74M$4.81M$4.47M$4.97M$4.44M$8.34M$7.55M$4.25M$3.94M$6.59M$3.80M$3.40M$3.26M$5.99M$2.94M$4.45M$4.09M$3.42M$3.36M$3.43M
Low Forecast$7.23M$6.82M$6.56M$6.17M$6.35M$5.91M$5.72M$5.38M$5.02M$4.80M$4.74M$4.58M$4.34M$4.97M$4.22M$5.56M$5.03M$4.25M$3.94M$4.39M$3.80M$3.40M$3.26M$3.99M$2.94M$4.45M$4.09M$2.28M$3.36M$3.43M
Surprise %-------------0.93%1.23%0.78%0.76%1.14%1.40%1.00%1.28%1.15%1.25%1.00%1.02%0.69%0.78%0.97%0.83%0.71%

KORU Medical Systems's average Quarter SG&A projection for Dec 23 is $4.35M, based on 3 Wall Street analysts, with a range of $4.34M to $4.47M. The forecast indicates a -5.91% fall compared to KRMD last annual SG&A of $4.62M (Sep 23).

KORU Medical Systems EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111133111311111111111111111
EPS-------------$-0.03$-0.05$-0.05$-0.04$-0.03$-0.07$-0.06$-0.02$-0.02$-0.03$-0.03$-0.02$0.01$-0.03$0.01$-0.00$0.02
Avg Forecast-$-0.01$-0.01$-0.02$-0.01$-0.02$-0.02$-0.02$-0.03$-0.04$-0.04$-0.04$-0.04$-0.05$-0.06$-0.05$-0.06$-0.05$-0.06$-0.06$-0.03$-0.02$-0.02$-0.01$-0.01$0.02$0.02$0.02$0.01$0.01
High Forecast-$-0.01$-0.01$-0.02$-0.01$-0.02$-0.02$-0.02$-0.03$-0.04$-0.04$-0.04$-0.03$-0.05$-0.05$-0.05$-0.06$-0.05$-0.06$-0.06$-0.03$-0.02$-0.02$-0.01$-0.01$0.02$0.02$0.02$0.01$0.01
Low Forecast-$-0.01$-0.01$-0.02$-0.01$-0.02$-0.02$-0.03$-0.03$-0.04$-0.04$-0.04$-0.05$-0.05$-0.06$-0.05$-0.06$-0.05$-0.06$-0.06$-0.03$-0.02$-0.02$-0.01$-0.01$0.02$0.02$0.02$0.01$0.01
Surprise %-------------0.60%0.97%1.06%0.77%0.50%1.02%1.00%0.71%1.01%1.26%4.35%3.35%0.51%-1.33%0.50%-0.20%3.30%

According to 1 Wall Street analysts, KORU Medical Systems's projected average Quarter EPS for Dec 20 is $-0.01, with a low estimate of $-0.01 and a high estimate of $-0.01. This represents a -156.94% decrease compared to KRMD previous annual EPS of $0.01 (Sep 20).

KORU Medical Systems Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ATRCAtriCure$31.50$39.6725.94%Buy
MMSIMerit Medical Systems$99.00$108.839.93%Buy
LMATLeMaitre Vascular$90.93$98.007.78%Buy
KRMDKORU Medical Systems$4.12$3.25-21.12%Buy

KRMD Forecast FAQ


Is KORU Medical Systems a good buy?

Yes, according to 3 Wall Street analysts, KORU Medical Systems (KRMD) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of KRMD's total ratings.

What is KRMD's price target?

KORU Medical Systems (KRMD) average price target is $3.25 with a range of $3 to $3.5, implying a -12.16% from its last price of $3.7. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will KORU Medical Systems stock go up soon?

According to Wall Street analysts' prediction for KRMD stock, the company can go down by -12.16% (from the last price of $3.7 to the average price target of $3.25), down by -5.41% based on the highest stock price target, and down by -18.92% based on the lowest stock price target.

Can KORU Medical Systems stock reach $6?

KRMD's average twelve months analyst stock price target of $3.25 does not support the claim that KORU Medical Systems can reach $6 in the near future.

What are KORU Medical Systems's analysts' financial forecasts?

KORU Medical Systems's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $38.15M (high $39.14M, low $37.29M), average EBITDA is $-5.497M (high $-5.373M, low $-5.64M), average net income is $-3.61M (high $-3.343M, low $-3.892M), average SG&A $23.9M (high $24.52M, low $23.36M), and average EPS is $-0.0787 (high $-0.0729, low $-0.0849). KRMD's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $43.76M (high $44.95M, low $42.75M), average EBITDA is $-6.305M (high $-6.16M, low $-6.478M), average net income is $-1.659M (high $-1.6M, low $-1.727M), average SG&A $27.41M (high $28.16M, low $26.78M), and average EPS is $-0.0362 (high $-0.0349, low $-0.0377).

Did the KRMD's actual financial results beat the analysts' financial forecasts?

Based on KORU Medical Systems's last annual report (Dec 2022), the company's revenue was $27.9M, beating the average analysts forecast of $26.51M by 5.24%. Apple's EBITDA was $-10.154M, beating the average prediction of $-4.368M by 132.48%. The company's net income was $-8.661M, beating the average estimation of $-8.116M by 6.72%. Apple's SG&A was $20.61M, beating the average forecast of $19.97M by 3.21%. Lastly, the company's EPS was $-0.19, missing the average prediction of $-0.231 by -17.90%. In terms of the last quarterly report (Sep 2023), KORU Medical Systems's revenue was $7M, missing the average analysts' forecast of $7.93M by -11.68%. The company's EBITDA was $-1.562M, beating the average prediction of $-1.143M by 36.71%. KORU Medical Systems's net income was $-1.368M, missing the average estimation of $-2.293M by -40.32%. The company's SG&A was $4.62M, missing the average forecast of $4.97M by -6.93%. Lastly, the company's EPS was $-0.03, missing the average prediction of $-0.05 by -40.00%